Principal Financial Group Inc. Has $8.19 Million Position in Envision Healthcare Co. (EVHC)

Principal Financial Group Inc. increased its position in shares of Envision Healthcare Co. (NYSE:EVHC) by 1.6% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 182,296 shares of the company’s stock after purchasing an additional 2,799 shares during the period. Principal Financial Group Inc. owned approximately 0.16% of Envision Healthcare worth $8,194,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. ING Groep NV grew its position in Envision Healthcare by 0.3% during the second quarter. ING Groep NV now owns 6,022 shares of the company’s stock worth $377,000 after buying an additional 21 shares during the period. CIBC Asset Management Inc grew its position in Envision Healthcare by 0.4% during the second quarter. CIBC Asset Management Inc now owns 10,078 shares of the company’s stock worth $632,000 after buying an additional 38 shares during the period. Sawtooth Solutions LLC grew its position in Envision Healthcare by 0.7% during the second quarter. Sawtooth Solutions LLC now owns 6,656 shares of the company’s stock worth $417,000 after buying an additional 43 shares during the period. Boys Arnold & Co. Inc. grew its position in shares of Envision Healthcare by 0.6% in the second quarter. Boys Arnold & Co. Inc. now owns 8,125 shares of the company’s stock valued at $509,000 after purchasing an additional 50 shares during the last quarter. Finally, PNC Financial Services Group Inc. grew its position in shares of Envision Healthcare by 1.5% in the second quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock valued at $304,000 after purchasing an additional 70 shares during the last quarter.

Shares of Envision Healthcare Co. (EVHC) opened at $30.53 on Thursday. The company has a quick ratio of 3.00, a current ratio of 3.01 and a debt-to-equity ratio of 0.89. Envision Healthcare Co. has a fifty-two week low of $23.77 and a fifty-two week high of $73.72. The stock has a market cap of $3,775.37, a price-to-earnings ratio of 9.64, a price-to-earnings-growth ratio of 0.81 and a beta of 0.57.

Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $2.03 billion. During the same period in the prior year, the company earned $1.13 EPS. The firm’s revenue was up 142.0% compared to the same quarter last year. equities research analysts forecast that Envision Healthcare Co. will post 2.57 earnings per share for the current fiscal year.

Envision Healthcare announced that its Board of Directors has authorized a share repurchase plan on Monday, September 18th that permits the company to repurchase $250.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 4.5% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board of directors believes its stock is undervalued.

EVHC has been the topic of several research reports. Robert W. Baird reiterated a “buy” rating and issued a $70.00 price target on shares of Envision Healthcare in a research report on Tuesday, October 17th. SunTrust Banks set a $55.00 price target on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Sunday, October 15th. Bank of America dropped their price target on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 9th. Jefferies Group set a $71.00 price objective on shares of Envision Healthcare and gave the stock a “buy” rating in a report on Thursday, August 24th. Finally, KeyCorp set a $67.00 price target on shares of Envision Healthcare and gave the company a “buy” rating in a report on Wednesday, November 1st. One research analyst has rated the stock with a sell rating, six have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. Envision Healthcare has a consensus rating of “Buy” and an average target price of $47.57.

WARNING: This article was published by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States & international copyright legislation. The original version of this article can be read at https://www.com-unik.info/2017/12/07/principal-financial-group-inc-has-8-19-million-position-in-envision-healthcare-co-evhc.html.

Envision Healthcare Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

What are top analysts saying about Envision Healthcare Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare Co. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit